Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis
2013; Wiley; Volume: 25; Issue: 1 Linguagem: Inglês
10.1111/pai.12140
ISSN1399-3038
Autores Tópico(s)Respiratory and Cough-Related Research
ResumoPediatric Allergy and ImmunologyVolume 25, Issue 1 p. 101-102 Correspondence Adverse drug reactions during ceftriaxone treatment can cause severe hemolysis Wei Liu, Wei Liu Weihai Municipal Hospital, Weihai, Shandong, 264200 ChinaSearch for more papers by this authorDongyan Yu, Dongyan Yu [email protected] Weihai Jingqu Hospital, Weihai, Shandong, 264205 ChinaSearch for more papers by this author Wei Liu, Wei Liu Weihai Municipal Hospital, Weihai, Shandong, 264200 ChinaSearch for more papers by this authorDongyan Yu, Dongyan Yu [email protected] Weihai Jingqu Hospital, Weihai, Shandong, 264205 ChinaSearch for more papers by this author First published: 07 October 2013 https://doi.org/10.1111/pai.12140Citations: 7Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program 2009: 73–9. doi: 10.1182/asheducation-2009.1.73. 10.1182/asheducation‐2009.1.73 Google Scholar 2Pierce A, Nester T. Pathology consultation on drug-induced hemolytic anemia. Am J Clin Pathol 2011: 136: 7–12. 10.1309/AJCPBVLJZH6W6RQM PubMedWeb of Science®Google Scholar 3Spath P, Garratty G, Petz L. Studies on the immune response to penicillin and cephalothin in humans. II. Immunohematologic reactions to cephalothin administration. J Immunol 1971: 107: 860–9. 10.4049/jimmunol.107.3.860 CASPubMedWeb of Science®Google Scholar 4Garratty G, Postoway N, Schwellenbach J, McMahill PC. A fatal case of ceftriaxone (Rocephin)-induced hemolytic anaemia associated with intravascular immune hemolysis. Transfusion 1991: 31: 176–9. 10.1046/j.1537-2995.1991.31291142951.x CASPubMedWeb of Science®Google Scholar 5Boggs SR, Cunnion KM, Raafat RH. Ceftriaxone-induced hemolysis in a child with Lyme arthritis: a case for antimicrobial stewardship. Pediatrics 2011: 128: e1289–92. 10.1542/peds.2010-1570 Web of Science®Google Scholar 6Seltsam A, Salama A. Ceftriaxone-induced immune haemolysis: two case reports and a concise review of the literature. Intensive Care Med 2000: 26: 1390–4. 10.1007/s001340000598 CASPubMedWeb of Science®Google Scholar Citing Literature Volume25, Issue1February 2014Pages 101-102 ReferencesRelatedInformation
Referência(s)